Latest Taxation News

BlackRock Investment Management (Australia) Limited has announced estimated cash distributions for a suite of Australian domiciled iShares ETFs, outlining key dates and participation details for investors.

Australia and New Zealand Banking Group Limited (ANZ) has announced a quarterly distribution of AUD 1.4438 per security on its capital notes, payable in June 2026, with a 70% franking component and tax considerations for investors.

Alcoa Corporation has updated its dividend notification for the quarter ending December 2025, clarifying currency exchange rates and payment methods for its shareholders.

Atlas Arteria has announced an ordinary dividend of AUD 0.20 per security for the six months ending December 2025, payable in April 2026. The dividend is fully unfranked, reflecting foreign income components.

Adelong Gold Limited has received a $1.17 million tax indemnity claim linked to alleged fraudulent GST reporting at Challenger Mines, which it plans to dispute. The claim stems from activities predating the current management team.

Resonance Health has received a $732,851 refund from the Australian Taxation Office, reflecting its FY2025 R&D tax incentive claim net of income tax payable. This cash inflow strengthens the company’s financial position ahead of its March quarterly report.

FAR Limited has agreed on a provisional US$23.7 million contingent payment from Woodside Energy tied to the Sangomar Project, prompting a proposed capital return of A$32.3 million to shareholders.

The Brazilian government has imposed a 12% tax on crude oil exports effective immediately, a move framed as windfall profit sharing amid high oil prices. Karoon Energy, with significant Brazilian operations, faces new cost pressures as the tax awaits potential ratification by Congress.

Janus Electric has locked in a $2.75 million R&D finance facility, strengthening its cash position to push forward with its zero-emission transport innovations. This strategic funding avoids shareholder dilution while supporting ongoing technology development.

Chimeric Therapeutics has secured a $1.785 million advance against its anticipated FY26 Research and Development Tax Incentive to bolster its clinical trial pipeline and working capital.

Betashares Capital Ltd has announced the final distribution amounts for February 2026 across a broad range of its ETFs listed on the ASX AQUA market, alongside details on the Distribution Reinvestment Plan.

Hydrix Limited reported a 14% revenue decline and a sharp increase in net loss for H1 2026, raising concerns about its financial stability despite securing a major contract.